PremiumRatingsEvolent Health’s Promising Financial Outlook Justifies Buy Rating Evolent Health Nominates Shawn Guertin to Board MCOs’ ‘mixed messages’ creating volatility in value-based care, says Truist PremiumCompany AnnouncementsEvolent Health Inc. Reports Mixed Earnings Results Evolent Health: Strong Long-Term Outlook with Projected 20%+ Annual EBITDA Growth and Improved Visibility Evolent Health price target lowered to $16 from $17 at Piper Sandler PremiumThe FlyEvolent Health sees Q1 revenue $440M-$447M, consensus $592.1M EVH Earnings Report this Week: Is It a Buy, Ahead of Earnings? Evolent Health Strengthens Board with Strategic Changes 
